Article · 29 Aug 2026
Conference abstract
Development of DNA vaccine against anthrax, botulism and smallpox with dual vector system
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Bioterrorism is a major topic in the 21st century, Bacillus anthracis, the bacterial pathogen responsible for anthrax, variola virus, the pathogenetic agent of smallpox and Clostridium botulinum, the pathogen trigger to botulinum that could be a potential biological weapon. The needs for the development of safe and effective vaccine are emerging against a biological weapon that can be used for bioterrorism. In this study, we would prove the efficacy of advanced DNA vaccine encoding D4, L1R, and HCR with dual vector system. The D4 contains the epitopes necessary for generating protective immunity to Bacillus anthracis. The L1R protein is required for vaccinia virus entry into host cells and is a target for neutralizing antibody. The HCR is the heavy chain receptor binding domain of botulinum neurotoxin. We used intramuscular electroporation to improve the cell uptake of dual DNA vector in Balb/c mice, and it showed that two dual DNA vectors (anthrax/botulinum, botulinum/ smallpox) induced high immune responses and high antibody titers against each target in mice. But anthrax/smallpox dual DNA vector was shown a low immune response, so we introduced intradermal electroporation using Tweezertrodes, more improved electroporation method. Intradermal electroporation method showed remarkably increased immune responses compare to intramuscular electroporation method. To develop anthrax/smallpox dual targeted DNA vaccine, we compared the dual vector system and mixed single vector system against anthrax/smallpox. The dual DNA vector system revealed relatively low immune response compared to mixed single vector system. We suggest that the dual vector systems can be candidates for the dual-targeted DNA vaccine against anthrax, botulism, and smallpox and in case of anthrax/smallpox, mixed single vector system using intradermal electroporation method is an effective way to develop DNA vaccine.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Min Hoon Lee”
- BylineArticles whose byline prints “Na Young Kim”
- BylineArticles whose byline prints “Sungyoul Hong”
- BylineArticles whose byline prints “Gyeung Haeng Hur”
- BylineArticles whose byline prints “Young Kee Shin”